This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why

Submitted by admin on February 10, 2019 - 1:48pm

Source:

Investors Business Daily

News Tags:

uniQure

M&A

hemophilia B

AMT-061

Pfizer

Spark Therapeutics

Headline:

This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why

snippet:

Gene therapy player Uniqure could garner takeover interest, an analyst said Friday after the biotech unveiled promising data in hemophilia B. Uniqure rivals Pfizer and Spark Therapeutics.

Search form

You are here

This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why

This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why